Loading

Annals of Pediatrics and Child Health

Why Pyloric Stenosis of Infancy Occurs-Facing the Facts

Research Article | Open Access

  • 1. Department of Surgery, AIMST University, Malaysia
+ Show More - Show Less
Corresponding Authors
IAN M. ROGERS, Department of Surgery, AIMST University, 46 Whitburn Road, Cleadon, Tyne and Wear, SR67QS, Kedah, Malaysia, Tel: 01915367944;07772967160
ABSTRACT

Background: There has been no shortage of published articles about pyloric stenosis of infancy(PS). Curiously, few have opined a cause despite a galaxy of potentially informative clues. The earliest speculative suggestion was that hyperacidity was involved. More recently the notion that there is a deficit of a relaxing agent-nitric oxide(NO) in the sphincter. Others have proposed that there is an abnormal accumulation of growth factors which leads to sphincter hypertrophy. Neither the NO nor the growth factor theories have attempted to link with the classical clinical features.

Materials and methods: The accepted physiological facts and the classical clinical features are linked in a comprehensive theory of cause. An inherited greater than average acid secretory ability is key. An important support is provided by two other normal developmental phenomena- a peak acidity in the early weeks and a temporary insensitivity of the negative feed-back between neonatal gastrin and gastric acidity soon after birth. Inappropriate overfeeding is an important stimulus for sphincter contraction. The evidence for its contribution to pathogenesis is also examined.

Results and conclusion: The Primary Hyperacidity theory has been found to expain all the clinical features.In outlining a conflict between stenosing forces and relaxing forces, it also provides and explanation for the way in which symptoms and signs may come and go.The theory is critically examined and is proposed as the cause.

CITATION

Rogers IM (2020) Why Pyloric Stenosis of Infancy Occurs-Facing the Facts. Ann Pediatr Child Health 8(3): 1177.

KEYWORDS

•    Neonatal hyperacidity
•    Neonatal hypergastrinaemia
•    Pathogenesis of pyloric stenosis of infancy
•    Trans-placental transfer of gastrin
•    H2 receptor blockade in neonates

INTRODUCTION

There has been no shortage of articles published about the still misunderstood condition of Pyloric Stenosis of Infancy (PS) (Figure 1).

1. The astonishing fact is that almost none, until very recent years, has proposed theories of cause. Almost all have only yet again confirmed from their own practice or from meta-analysis the classical signs, symptoms and demographics of this enigmatic disease. The few recent scientific attempts such as the alleged abnormal accumulation of growth factors in the sphincter [1], and the nitric oxide theory [2], have not stood the test of time. Neither theory has addressed the need to explain the clinical spectrum; both have reported findings that you would expect in a frequently contracting sphincter and the growth factor theory has never had any adequate controls. The real cause has remained a mystery. The elephant in the room has been studiously ignored.

2. Possible reasons for this antipathy towards a comprehensive cause, no doubt relate to the ease of modern ultrasound diagnosis and surgical cure. However, multiple support groups exist online such as pyloric stenosis support group which frequently reveal frustration and worry-largely about delayed and mistaken diagnosis. Pediatricians wisely have confined themselves to diagnosis and rapid referral given that medical cures are less certain, do have side effects and take much longer.

For a medical detective seeking the cause, the clues are not in short supply. What happens when you face the facts?

MATERIALS AND METHODS-THE THEORY

There are several facts concerning pyloric stenosis of infancy (PS) , which are beyond dispute.

1. The tumor is caused by hypertrophy of the circular muscle fibers of the sphincter [3].

2. Repeated contraction will cause sphincter work hypertrophy especially under the trophic influence of neonatal hypergastrinaemia [4]. Hypertrophy occurs naturally when growth factors are attracted by repeated contraction.

3. Pyloric stenosis (PS) babies are hypersecretors of acid even after successful pyloromyotomy [5,6], and hyperacidity is a potent cause of sphincter contraction [7,8]. The mechanism of acid induced sphincter contraction is not yet conclusively established. Duodenal acidity stimulates cholecystokinin and secretin, both of which cause sphincter contraction [8], and prostaglandin, released locally from the stomach in response to gastric hyperacidity, has a similar effect.

4. H2 receptor blockade rapidly reduces alkalosis and allows same day surgery. Hence an active real time hypersecretion of acid must be present rather than retention of acid behind a closed pylorus [9].

This statement is further strengthened by the observations that any vomiting baby in the PS age range with an alkalosis, will have PS [10], and that hyperacidity problems more frequently supervene in adult life [11].

The strong family history adds weight to the working hypothesis. PS babies will inherit an acid secreting ability above normal; the pylorus will contract more often and the subsequent sphincter work hypertrophy will produce PS. These simple theory, detective-like, needs to be tested in relation to the classical clinical features.

Male predominance

Male premature infants secrete more acid than females [12]. There are no comparative studies in term babies. The classical ratio of 4-5/1 parallels the sex-ratio of adult duodenal ulcer (DU), patients-a condition known to depend on hyperacidity. PS babies like DU adults also have a greater frequency of blood group O [13,14].

The presentation at 4 weeks: Fasting gastrin levels rise quickly after birth in all normal babies and do not fall despite the rising gastric acidity in the first few weeks of life. When both gastrin and acid secretion rise together (such as in the ZollingerEllison syndrome) the negative feedback between gastrin and antral acidity is not working [4,15,16]. There is evidence which suggests this applies also to the PS baby.

Support for an initial immaturity of the negative feed-back also comes from other sources. There is a reduced or absent post-feed gastrin response in the first few weeks of life [17]. During this time gastrin is being maximally secreted without restraint from acidity, and feeding cannot increase it further.

Moreover, in normal development, the maximally stimulated acid secretion and fasting acid secretion are the same [18], during the first day of life. The stimulus for gastrin secretion is unrestrained from day 1.

Neither acid nor gastrin, at this time, inhibits the other as they do in adult life. When negative feed-back is established at around 3 weeks a temporary peak acidity is predicted on this physiological basis and it has been shown to occur at around 2-3 weeks of life just when negative feed-back is being established [19] (Figure 2).

In normal babies an early rise in acidity from a temporary maternal gastrin boost and peak acidity (from a maturing feed-back) protects against enteric infections and does not harm (19). In babies already with an inherited hyperacidity, the hyperacidity will cause frequent sphincter contractions, hypertrophy and Pyloric Stenosis. It is not surprising that vomiting will begin around 4 weeks-soon after the time of peak acidity.

The condition self-cures if the babies can be kept alive for long enough: When the feed-back matures, gastrin will be expected to fall and, for the first-time since birth, a post-prandial gastrin response will occur. This phenomenon has already been confirmed [17]. The reporting authors described their findings as being best explained by an early insensitivity of the negative feedback. The maturing negative-feedback will also explain the known reduction in acidity at that time.

The reduced acid drive to pyloric contraction coupled with age -related widening of the lumen will combine to produce self-cure.

This sequence of events finds support in the acid studies of Agunod and also of Hyman which reveal that, in normal development, acid secretion rises to a peak at around 2-3 weeks of age before slowly falling within the next few weeks [16,19] (Figure 2).

Why does pyloromyotomy produce a long-term cure?

Sphincter division makes contraction impossible. Work hypertrophy can no longer occur. In any event, by this time the time for peak hyperacidity will have passed.

Why the family history in 25% of PS babies?

Constitutional hyperacidity is inherited on a multifactorial basis both by PS babies and DU patients and is also the pattern of inheritance of PS [20].

The first- born and the feeding phenomenon.

First born babies are born to novice mothers. In two consecutive studies from Birmingham U.K. involving 1059 PS babies from 1940-1951, it was concluded that the earlier presentation of home-fed babies was caused by 3 hourly home feeds compared to 4 hourly hospital feeds [21,22]. Sphincter contractions are most frequent and most powerful after a feed when the feed is being mixed against a frequently closing pylorus [23].

In this huge series the first-born predominance was only apparent from week 3 onwards. There was a clear environmental factor which acts after birth and takes 2 weeks to have an effect. That factor was over frequent feeding-a practice more likely to be associated with an anxious novice mother [21,22].

The bigger picture-acid defence versus acid attack

Neonatal gastric acid protects against enteric infections. Hence a system to kick-start acidity soon after birth and to maintain acidity in the first few days before it rises naturally with rising gastrin, would have a survival advantage. An early wave of acidity occurring a few hours after birth was first described in 1947 [24]. The phenomenon was thought to be due to a maternal hormone transmitted from mother to baby during labour which would cause gastric acid secretion. There is much evidence now to support trans-placental gastrin transfer during labour as the cause.

Maternal plasma gastrin rises progressively during pregnancy and peaks at birth [25]. Within 30 minutes of delivery the levels fall. The maternal placenta is rich in gastrin [26], and at birth the fasting foetal gastrin levels are significantly higher than in the fasting maternal venous samples [2]. Gastrin is known to cross from mother to baby in dogs and to actively cause acid secretion [27].

All of this point to trans-placental transfer of gastrin in humans which would cover the acid gap before progressive acidity generated by the temporary negative feed-back begins. These developmental mechanisms give a survival advantage to normal babies. One disadvantage is the development of PS in the baby with inherited hyperacidity.

Professor Dodge and the canine model

Puppy dogs born to mothers who had received injections just before labour develop sphincter hypertrophy identical to PS. [28]. Even more puppies developed PS when they receive the injections after birth. These experiments are crucial to our understanding of pathogenesis since gastric outlet stenosis itself leads to increased acid secretion [29].

The puppy experiment in producing PS from an otherwise normal development shows that the prime mover is indeed hyperacidity. While gastric outlet stenosis increases acid secretion it occurs only after the event-it does not initiate it.

The classical and effective conventional medical treatment originally designed in the hope of reducing pyloric “spasm” [30], may do so by removing acidity directly by gastric washouts and indirectly by reducing vagal- induced acid secretion through atropine. Relatively underfeeding is also important in any successful medical treatment, since it removes another important driver of sphincter contraction [23].

RESULTS

This theory is supported by the observation that preoperative cimetidine therapy in early cases of PS with a sphincter diameter of 4 mm. or less [31], will produce a long-term cure in 17/18 babies.

In 1921 Dr. John Thompson after an analysis of 100 PS babies in the preceding 25 years proposed pylorospasm and work hypertrophy as the cause although no primary cause was defined [32].

He divided the presentation of PS into 3 groups –

A) an acute form with violent symptoms-

B) an ordinary form-and most importantly-

C) the mild cases.

The mild cases were not at all uncommon-they slipped in and out of PS. No doubt this would be a reflection of the conflict between factors increasing acidity or pyloric contraction (emerging gastric hold up and inappropriate feeding) and factors favoring natural cure such as the time related reduction in acidity and widening of the pyloric lumen with age. Most experienced medical or surgical observers will have had cause to reflect that, in the words of MacKeown after an experience of analyzing 1059 PS babies from Birmingham U.K.-the presentation is “rarely sharp” [21].

CONCLUSIONS

Nothing has really changed. We all continue to stand on the shoulders of those who have gone before. One such worthy was Dr.W. Freund who in 1903, untrammelled by sophisticated science, found the hydro-chloric acid content to be in excess of normal. He concluded that acid was the cause of “spasm” of the pylorus [33]. In observing hyperacidity, he joined forces who were using alkalis in the treatment and with the American Hezekiah Beardsly (1788), and the later opinion of the Australian Austin Lendon (1912) [34,35]. It was however Freund who specifically related hyperacidity to the pathogenesis.

Despite the many articles about chemical growth mediators, nitric oxide abnormalities with knock-out mice etc., none of these theories addresses the need to explain the clinical features. None has stood the test of time.

The hyperacidity theory explains all of them.

REFERENCES

1. Guarino N,Shima H, Oue T, Puri P. Glial derived growth factor signaling pathways in I.H.P.S. J Ped Surg. 2000; 35: 835-839.

2. Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ, De Laet MH. Nitric oxide synthetase activity in IHPS. N Eng J Med. 1992; 307: 511-515.

3. Oue T, Puri P. Smooth muscle hypertrophy versus hyperplasia in IHPS. Pediatr Res. 1999; 45: 853-857.

4. Rogers IM, Davidson DC, Lawrence J, Ardill J, Buchanan KD. Neonatal secretion of gastrin and glucagon. Arch Dis Child. 1974; 49: 796-801.

5. Heine W, Grager B, Litzenberger M, Drescher U. Results of Lambling gastric juice analysis (histamine stimulation) in infants with spastic hypertrophic pyloric stenosis. Padiatr Padol. 1986; 21: 119-125.

6. Rogers IM, Drainer IK, Dougal AJ, Black J, Logan R. Serum cholecystokinin, basal acid secretion and infantile hypertrophic pyloric stenosis. Arch Dis Childhood. 1979; 54: 773-775.

7. Rogers IM. Hyperacidity, overfeeding, prostaglandins, and pyloric stenosis of Infancy. J Ped Surg. 2019; 54; 2636-2637.

8. Cook AR. Duodenal acidification: Role of the first part of the duodenum in gastric emptying and secretion in dogs. Gastroenterology. 1974; 67: 85-92.

9. Fisher RS, Lipshutz W, Cohen S. The hormonal regulation of the pyloric sphincter function. J Clin Invest. 1973; 52: 1289-1296.

10. Banieghbal B. Rapid correction of metabolic alkalosis in hypertrophic pyloric stenosis with intravenous cimetidine: preliminary results. Pedatr Surg Int. 2009; 25: 269-271.

11. Maizels M. Alkalosis in the vomiting of infancy. Arch Dis Child. 1931; 1: 293-302.

12. Wanscher B, Jensen HE. Late follow-up studies after operation for congenital pyloric stenosis. Scand J Gastroenterol. 1971; 6: 597-599.

13. Ames Mary. Gastric acidity in the first 10 days of life of the prematurely born baby. Amer J Dis Child. 1959; 2: 1123-1126.

14. Dodge JA. ABO blood groups and IHPS. BMJ. 1967; 4: 781-782.

15. Koster KH, Sindrup E. Seele V. ABO blood groups and gastric acidity. The Lancet. 1955; 9: 52-56.

16. Waldum HI, Fossmark R, Bakke I, Martinsen C, Qvigstad G. Hypergastrinaemia in animals and man: causes and consequences. Scand J Gastroenterol. 2004; 39: 505-509.

17. Hyman PE, Clarke DD, Everett SL, Sonne B, Stewart D, Harada T et al. Gastric secretory function in pre-term infants. Pediatrics. 1985; 106: 467-468.

18. Moazam F, Kirby WJ, Rodgers BM, McGuigan JE. Physiology of serum gastrin production in neonates and infants. Ann Surg. 1984; 389-392.

19. Euler AR, Byrne WJ, Meisse PJ, Leake RD, Ament MF. Basal and pentagastrin stimulated acid secretion in new-born infants. Ped Res. 1979; 13: 36-37.

20. Agunod M. Correlative study of hydrochloric acid, pepsin and intrinsic factor secretion in newborns and infants. Amer J Digest Dis. 1969; 14: 400-413.

21. Carter CO. The inheritance of congenital pyloric stenosis. Br Med Bull. 1961; 17: 251-254.

22. McKeown T, McMahon B. Evidence of post-natal environmental influence in the aetiology of infantile pyloric stenosis. Arch Dis Child. 1952; 27; 386-390.

23. Gerrard JW, Waterhouse JAH, Maurice DG. Infantile pyloric stenosis. Arch Dis Child. 1955; 30: 493-496.

24. Ehrlein H, Shemann M. Gastro-intestinal motility.

25. Miller RA. Observations on the gastric acidity during the first month of life. Arch Dis Childhood. 1941; 16: 22-30.

26. Attia R, Ebeid AM, Fischer JE, Goudsouzian NG. Maternal foetal and placental gastrin concentrations. Anaesthesia. 1982; 37: 18-21.

27. Attia RR, Ebeid AM, Murray P, Fischer JE. The placenta as a possible source of gut peptide hormones. Surg Forum. 1976; 27: 432-434.

28. Bruckner WL, Snow H, Fonkalsrud EW. Gastric secretion in the canine foetus following maternal stimulation: Experimental studies on placental transfer of insulin, histamine and gastrin. Surgery. 1970; 67: 360-363.

29. Dodge JA, Karim AA. Induction of pyloric hypertrophy by pentagastrin. Gut. 1976; 17: 280-284.

30. Crean GP, Hogg DF, Rumsey RDE. Hyperplasia of the gastric mucosa produced by duodenal obstruction. Gastroenterology. 1969; 56: 193- 199.

31. Jacoby NM. Pyloric stenosis. Selective medical and surgical treatment. Lancet. 1962; 119-121.

32. Banieghbal. B. Personal communication. 2013

33. Thomson J. Observations on congenital hypertrophy of the pylorus. Edin Med J. 1921; 26: 1-20.

34. Freund W. Mitt. a. d.Grenzgreb. dMed. u. Chir. 1903; 11: 309.

35. Beardsly Hezikiah. Cases and observations by the Medical Society of of New Haven County in the State of Connecticut. New Haven. 1788.

36. Lenden AA. Congenital Hypertrophic Pyloric Stenosis. Aus Med J. 1912; 6: 417-419.

Rogers IM (2020) Why Pyloric Stenosis of Infancy Occurs-Facing the Facts. Ann Pediatr Child Health 8(3): 1177.

Received : 10 Apr 2020
Accepted : 25 Apr 2020
Published : 29 Apr 2020
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X